Management and Treatment of Patients With Exon 20 Non–Small Cell Lung Cancer

This roundtable series reviews molecular testing in non–small cell lung cancer and potential treatments for patients with EGFR exon 20 mutations, as discussed by key opinion leaders and participants at virtual live events.